AMERICAN INTERNATIONAL GROUP, INC. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,225
-7.9%
51,675
+3.7%
0.00%
Q2 2023$57,812
-22.9%
49,838
+0.3%
0.00%
Q1 2023$75,002
-38.4%
49,670
+2.0%
0.00%
-100.0%
Q4 2022$121,703
-40.9%
48,681
-0.4%
0.00%0.0%
Q3 2022$206,000
+53.7%
48,858
+1.4%
0.00%0.0%
Q2 2022$134,000
-48.9%
48,168
+5.0%
0.00%0.0%
Q1 2022$262,000
-41.5%
45,869
-6.6%
0.00%
-50.0%
Q4 2021$448,000
-17.2%
49,097
-2.9%
0.00%
-33.3%
Q3 2021$541,000
-32.6%
50,567
-2.3%
0.00%0.0%
Q2 2021$803,000
-3.0%
51,768
+1.4%
0.00%0.0%
Q1 2021$828,000
-23.2%
51,074
+0.3%
0.00%
-25.0%
Q4 2020$1,078,000
+38.7%
50,938
-2.8%
0.00%0.0%
Q3 2020$777,000
-1.4%
52,400
-2.2%
0.00%0.0%
Q2 2020$788,000
+34.9%
53,592
+7.7%
0.00%
+33.3%
Q1 2020$584,000
-52.8%
49,759
-5.5%
0.00%
-40.0%
Q4 2019$1,237,000
+43.5%
52,634
+12.9%
0.01%
+66.7%
Q3 2019$862,000
-1.1%
46,604
-0.7%
0.00%0.0%
Q2 2019$872,000
-18.8%
46,929
+6.8%
0.00%
-25.0%
Q1 2019$1,074,000
-8.8%
43,956
-3.1%
0.00%
-20.0%
Q4 2018$1,177,000
-18.7%
45,381
-0.8%
0.01%0.0%
Q3 2018$1,447,000
-10.4%
45,731
+10.0%
0.01%
-16.7%
Q2 2018$1,615,000
+68.6%
41,565
+19.8%
0.01%
+100.0%
Q1 2018$958,000
+72.9%
34,709
+13.4%
0.00%
+50.0%
Q4 2017$554,000
+12.6%
30,602
+0.5%
0.00%0.0%
Q3 2017$492,000
+26.2%
30,457
+8.1%
0.00%
+100.0%
Q2 2017$390,000
+2.6%
28,180
+11.2%
0.00%0.0%
Q1 2017$380,000
+59.0%
25,332
+38.6%
0.00%0.0%
Q4 2016$239,000
-99.9%
18,273
-0.3%
0.00%0.0%
Q3 2016$315,671,000
-4.4%
18,321
+0.2%
0.00%0.0%
Q2 2016$330,189,000
+2.9%
18,293
+8.1%
0.00%0.0%
Q1 2016$321,000,000
-16.6%
16,924
+17.2%
0.00%
-50.0%
Q4 2015$385,000,000
+108965.2%
14,435
-0.2%
0.00%0.0%
Q3 2015$353,000
-99.9%
14,460
+0.1%
0.00%0.0%
Q2 2015$450,044,000
+111.2%
14,443
-1.4%
0.00%
+100.0%
Q1 2015$213,099,000
+44.6%
14,6460.0%0.00%0.0%
Q4 2014$147,339,000
+38.6%
14,646
+14.8%
0.00%
Q3 2014$106,291,000
-34.8%
12,760
-3.6%
0.00%
-100.0%
Q2 2014$163,018,000
+9667.4%
13,232
+10926.7%
0.00%
Q1 2014$1,669,0001200.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders